| CHRS Stock Yearly Return 2018 Table | ||||||||||||||||||||||||||||||
CHRS average annual return is presented with the assumption of reinvestments of any dividends on ex-date. |
| Average Annual Return Benchmarks |
|
Compare CHRS average annual return versus benchmarks: S&P Average Annual Return Dow Average Annual Return Nasdaq 100 Average Annual Return Russell 2000 Average Annual Return Gold Average Annual Return 10 Year Treasury Average Annual Return |
| CHRS Share Performance |
| CHRS Stock Yearly Return 2018 Chart | |||
Also see: • CHRS stock yearly return 2019 • CHRS stock yearly return 2020 • CHRS YTD return • CHRS average annual return 10 years | |||
| About Coherus BioSciences Inc |
| Coherus BioSciences is a commercial-stage biotherapeutics company focused on the biosimilar and immuno-oncology market. Co.'s product, UDENYCA® (pegfilgrastim-cbqv) is a biosimilar to Neulasta®, a long-acting granulocyte-colony stimulating factor. Co.'s pre-commercial pipeline includes the following product candidates: Toripalimab, an anti-PD-1 antibody being developed in collaboration with Shanghai Junshi Biosciences, Co., Ltd.; a bevacizumab (Avastin) biosimilar candidate in collaboration with Innovent Biologics (Suzhou) Co., Ltd.; CHS-1420 (its adalimumab (Humira) biosimilar candidate); and a ranibizumab (Lucentis) biosimilar candidate in collaboration with Bioeq IP AG. The CHRS stock yearly return is shown above.
The yearly return on the CHRS stock yearly return page and across the coverage universe of our site, is a measure of the annual return over the calendar year 2018 for the given stock. When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is more than just the change in price if that instrument pays a dividend or coupon. One way to factor dividends into the return is simply to count them as cash — we don't do that here. Instead, our website aims to empower investors by performing the CHRS annual return calculation with any dividends reinvested as applicable (on ex-dates). |
| CHRS Current Stock Quote |
Get Free SEC filing alerts for CHRS:
CHRS SEC Filing Email Alerts Service 
|
| Video: Don't Forget Dividends in Annual Return! | |
|
| Yearly Return Peers |
| Coherus BioSciences (CHRS) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:
CIVI Average Annual Return |
Video: Don't Forget Dividends in Average Annual Return!